tirzepatide 10 mg/0.5 ml (weight loss) subcutaneous solution Zepbound (Tirzepatide) Weight Loss Pen

If youre not losing weight, talk to your doctor about dose adjustments, dietary changes, or additional strategies to support your treatment goals

Among non-diabetic patients, a significant increase in hypoglycemia was observed with the 5 mg dose (OR=9.30, 95% CI: 1.1873.66, p=0.03)

Overall, tirzepatides dual agonism of GLP1 and GIP receptors appears to provide encouraging cardiovascular benefits beyond glycemic control, offering a potential new therapeutic option for treating cardiovascular diseases and heart failure

18 July 2022

And that is why it works

Keep vials in their box, and bring extra needles, alcohol swabs, and a sharps container or travel-safe disposal kit